HIPRAGUMBORO-G97

Страна: Ірландія

мова: англійська

Джерело: HPRA (Health Products Regulatory Authority)

Активний інгредієнт:

Live Infectious Bursal Disease Virus, strain GM97

Доступна з:

Laboratorios Hipra S.A.

Код атс:

QI01AD09

ІПН (Міжнародна Ім'я):

Live Infectious Bursal Disease Virus, strain GM97

Дозування:

.

Фармацевтична форма:

Lyophilisate for oculonasal suspension/use in drinking water

Тип рецепту:

POM: Prescription Only Medicine as defined in relevant national legislation

Терапевтична група:

Chickens

Терапевтична области:

avian infectious bursal disease virus (gumboro disease)

Терапевтичні свідчення:

Immunological - Live Vaccine

Статус Авторизація:

Authorised

Дата Авторизація:

2015-05-29

Характеристики продукта

Health Products Regulatory Authority
10 December 2019
CRN009DWR
Page 1 of 4
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
HIPRAGUMBORO-G97
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Composition per dose:
ACTIVE SUBSTANCE:
- Live Infectious Bursal Disease Virus, strain GM97: 10
2
- 10
3
EID
50
(embryo infective dose 50%).
EXCIPIENTS AND ADJUVANTS WHERE KNOWLEDGE OF THIS IS ESSENTIAL FOR THE
SAFE ADMINISTRATION OF THE MEDICINAL PRODUCT:
None.
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Lyophilisate for oral suspension.
Appearance: reddish tablet.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Species: Chickens.
Category: Broilers.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For active immunisation of broilers with insignificant levels of
maternally derived antibodies (ELISA of 500 or below) to reduce
mortality, clinical signs and bursal lesions of Gumboro disease. Such
birds can be vaccinated from one day of age. The onset of
immunity is 14 days post vaccination and the duration 43 days post
vaccination.
4.3 CONTRAINDICATIONS
Do not vaccinate sick birds.
Do not use in infected flocks showing clinical signs.
Since no studies to demonstrate the safety of this vaccine when it is
administered to layers and breeders have been carried out,
its use is not recommended for these categories of the target species
(see section 4.7).
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Use only in flocks with low levels of maternal antibodies (mean ELISA
titres ≤500). The optimum day of vaccination of broilers
with maternal antibodies is calculated according to the
Kouwenhoven’s formula (see section 4.9 posology).
Due to its residual pathogenicity to the bursa the vaccine should be
used only in areas contaminated with vvIBDV, except for
infected flocks showing clinical signs.
See section 4.3.
Health Products Regulatory Authority
10 December 2019
CRN009DWR
Page 2 of 4
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
- Do not use water with chlorine